Nifty Pharma Rebounds After Tariff-Led Selloff

The Nifty Pharma index rose 1% on September 29, ending a five-day fall as 15 of 20 stocks gained up to 2%. Analysts noted India’s generic exports to the US remain outside Trump’s new 100% drug tariffs, making last week’s selloff sentiment-driven.

Sun Pharma and Biocon face the most risk, though broader impact may arise if tariffs widen.